The aim of this work was to study the interaction between genetic polymorphisms (singlenucleotide polymorphisms, SNPs) of pro-and anti-infl ammatory cytokines and fat intake on the risk of developing Crohn ' s disease (CD) or modifying disease activity.
INTRODUCTION
Crohn ' s disease (CD) is a chronic infl ammatory condition, characterized by a predominantly T-helper 1 type response, which results in the upregulation of pro-infl ammatory cytokines, such as interleukin 6 (IL6), IL8, and tumor necrosis factor alpha (TNF ) (1, 2) . For this reason, agents able to reduce the secretion of pro-infl ammatory cytokines are in focus of research for the treatment of this disease. Besides steroids and other immunosupressants, and the more recently available anti-TNF agents, some studies focused on the nutritional manipulation of infl ammation, namely through the administration of polyunsaturated fatty acids (PUFAs) n-3. Diff erent fat sources with diff erent fatty acids profi le, seem to have diff erent eff ects on the expression on diff erent cytokines (3) . In some studies, in which the anti-infl ammatory eff ect of n-3 fatty acid (fi sh oil) in patients with CD was examined, some discrepancies were observed (4, 5) . In addition, when Gassull et al. (6) tried to study the eff ects of PUFA n-6 vs. MUFA (monounsaturated
INFLAMMATORY BOWEL DISEASE
Guerreiro et al.
fatty acid) n-9, they found a higher remission rate in patients fed n-6 PUFA as opposed to what was expected. Th e reasons for these inconsistencies are not readily apparent but could result from diff erent host responses due to diff erent genetic polymorphisms (7) . In fact, more than 10 susceptibility loci for CD have been identifi ed which, in the presence of certain environmental stimuli, namely nutritional stimuli, could give rise to diff erent responses (8) . To our knowledge, no previous study has tried to examine the combined eff ect that genotype and nutrients might exert on CD susceptibility and activity.
Th e aim of this study was to investigate whether genetic polymorphisms of pro-and anti-infl ammatory cytokines genes were related to CD susceptibility or activity. We also examined whether there were any interactions between these SNPs of cytokine genes and the type of dietary fat in modulating disease activity in CD patients.
METHODS

Subjects
Th e study protocol was approved by the Ethics and Scientifi c Committees from both the IPOFG (Instituto Portugues de Oncologia Francisco Gentil) and from the University Hospital de Santa Maria, both located in the Lisbon area. All participants gave their informed and written consent before entering the study.
Outpatients with a confi rmed diagnosis of CD, who were coming for a routine visit to the outpatient clinic during the period of September 2004 until November 2007, were asked to participate in the study. Th e diagnosis was based on previously defi ned criteria (9) , and disease activity was assessed according to the Harvey -Bradshaw Index (HBI) (10) . None of the patients were on steroids at the moment of the study and none were hospitalized. Only patients with mild-to-moderate disease were included. Th e reason for that was because our aim was to explore the association between nutritional intake during the last year and disease activity during this same period. As we wanted to examine this relationship on a long-term basis, including hospitalized patients with severe disease would be a major bias. According to the HBI, 36 / 99 (36.4 % ) of patients had moderately active disease with a HBI ≥ 4, whereas the remaining 63 (63.6 % ) had inactive disease. Th ese activity indices refer to at least three visits during the 1-year period. Patients with severe active disease (HBI > 7) at the moment of patient inclusion or with the need of systemic steroids were excluded ( n = 7). All patients had a stable body weight during the 3 months preceding the study. All patients who fulfi lled the inclusion criteria and who were asked to participate in the study, accepted and were included. A total of 116 healthy blood donors from the IPOFG, with no previous history of infl ammatory bowel disease, were recruited as a control group for genotyping. Although controls were slightly older compared with CD patients (49.7 ± 11.8 vs. 40.4 ± 14.6; P < 0.01), the gender distribution was similar in both groups.
Dietary intake
Dietary intake was assessed using a semi-quantitative FFQ (food-frequency questionnaire), validated to the Portuguese population (11) , consisting of 86 food items with 9 possible answers with respect to the medium frequency intake (never or less than once a month, to six or more than six times a day), and with three possible answers with regard to the size of the portion (smaller, equal, or larger than the medium portion size). Dietary intake was analyzed in a modifi ed database Food Processor Plus soft ware, version 7 (ESHA Research, Salem, OR), which includes some Portuguese food items and which allows the quantifi cation of diff erent macronutrients and micronutrients. Participants were asked to recall their habits in the year before the interview. When analyzing the interaction between genetic and nutritional variables, the median value was considered because fat intake did not have a normal distribution. In our study population, intakes under or above the median value were considered low or high.
Genotype data
Whole blood samples from CD patients were collected and stored at − 20 ° C until use. DNA extraction was carried out with phenol -chloroform extraction. For controls, DNA was extracted from whole blood using the methodology described in the Generation Capture Card Kit -DNA Purifi cation / DNA Elution (Gentra Systems, Minneapolis, MN). PCR and restriction fragment length polymorphism techniques were used to analyze gene polymorphisms in IL1 , TNF , LT , and IL6 genes. 
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Fatty Acids, IL6, and TNF Polymorphisms albumin (BSA) for specifi c enzymes (TaqI , HincII , and NlaIII) , and H 2 O until the fi nal volume. Th e reaction took place for 2 h at 37 ° C for all polymorphisms, except for IL1 + 3,953C / T which was carried out at 65 ° C. Aft er digestion, the product run on 4 % gel genotypes for each subject was recorded.
Statistical methods
Statistical analysis was performed using SPSS version 16.0. for Windows (SPSS, Chicago, IL, EUA). Data were expressed as mean ± s.d., as number of subjects and (percentage) or as odds ratio (OR) and 95 % confi dence interval (95 % CI). Bivariate analyses were conducted using Student ' s t -test or Mann -Whitney test for continuous variables, and the 2 -test was used for categorical variables. Multiple logistic regression was used to assess the association between variables related to disease activity.
Statistical signifi cance was established for P < 0.05.
RESULTS
Th e baseline characteristics of 99 (60 women, 39 men, mean age 40.4 ± 14.6 years) enrolled patients with CD are listed in Table 1 . Although controls were slightly older than CD patients (49.7 ± 11.8 vs. 40.4 ± 14.6; P < 0.01), the gender distribution was similar in both groups. Table 2 shows the diff erent genotypes observed for both patients and controls. Except for individuals who were homozygous for the IL6 − 174G / C polymorphism, who showed a six-fold higher risk for CD (OR = 6.1; 95 % CI = 1.9 -19.4) when compared with controls, none of the other polymorphisms analyzed had any infl uence on the risk of developing CD. With respect to disease activity, the CD cohort was stratifi ed into active and inactive diseases according to whether HBI was ≥ 4 or < 4, respectively. When comparing the fat intake in these two groups of patients, we observed that a higher intake of total, saturated and monounsaturated fats was associated with a higher risk for active disease (OR = 2.56; 95 % CI = 1.1 -6.0; OR = 3.6; 95 % CI = 1.5 -8.6; OR = 3.3; 95 % CI = 1.4 -7.9, respectively). In addition, patients with a higher n-6 / n-3 PUFA intake also had a signifi cantly higher disease activity (OR = 2.3; 95 % CI = 1.0 -5.3) ( Table 3 ) . Table 4 shows the association between genotypes for cytokines genes and disease activity. We observed that the TT genotype on the TNF − 857 locus was the sole polymorphism associated with a higher disease activity (OR = 10.4; 95 % CI = 1.1 -94.1). None of the other genetic polymorphisms analyzed seemed to have any signifi cant association with disease activity.
As none of the other genetic polymorphisms showed signifi cant association with either disease susceptibility or disease activity, only TNF − 857C / T and IL6 − 174G / C polymorphisms were included in the interaction analysis between genotype and the type of fat intake ( Table 5 ) . We found that a high intake of saturated and monounsaturated fats, as well as a high n-6 / n-3 PUFA ratio were associated with higher disease activity, mainly in patients carrying the variant alleles of the 857 TNF polymorphism (OR = 6.0; 95 % CI = 1.4 -26.2; OR = 5.17; 95 % CI = 1.4 -19.2; OR = 5.92; 95 % CI = 1.3 -26.5). Although non-signifi cant because 95 % CI includes 1.0, but with a strong tendency, we also observed an association between the high intake of saturated and monounsaturated fats and the 174 IL6 polymorphism (OR = 2.95; 95 % CI = 1.0 -9.1; OR = 3.21; 95 % CI = 1.0 -10.4) and between the low intake of n-3 PUFA and the TNF polymorphic allele (OR = 3.6; 95 % CI = 1.0 -13.0). No diff erences were found when examining the relationship between disease behavior, previous need of steroids, Azathioprine, Metotrexate or surgery, and genetic polymorphisms, or the type and amount of fat intake. 
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DISCUSSION
It is increasingly clear that both environmental and host genetic factors are important in determining not only the susceptibility for CD but also disease behavior and response to therapy (7) . In this study, we have examined the eff ect of a number of polymorphisms of pro-and anti-infl ammatory cytokines in modifying the susceptibility for CD and disease activity. With respect to disease susceptibility, we found that individuals who were homozygous for the IL6 − 174G / C polymorphism were at increased risk of developing CD. Th e latter is a novel fi nding and not observed by previous authors (12,13) . Data from in vivo and in vitro studies suggest that the GG genotype (wild type) is associated with a greater production of IL6 compared with GC or CC genotypes (14) . IL6 is a multifunctional cytokine that stimulates the hepatic acute phase response, as well as the diff erentiation and activation of macrophages and T cells (15) . Contrary to what could be expected, we found a signifi cantly higher risk for CD in individuals homozygous for this polymorphism, but no association was observed with disease activity. Although the association with increased susceptibility was unexpected, it is worth recalling that although the CC polymorphism may lead to a low production of IL6, there 
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More interesting were the interactions that we found between genetic and nutritional factors. In the 80s, O ' Morain et al. (17) were among the fi rst to report that an elemental diet could be as eff ective as steroids in inducing remission in CD patients. Th e authors hypothesized that the mechanism of action of this type of enteral nutrition could be related to its lower antigenicity, as protein was given as dipeptides or amino acids. However, in the 90s, three meta-analyses of randomized controlled trials comparing steroids and enteral nutrition failed to disclose any diff erences in response when amino acids vs. whole-protein-based diets were used (18 -20) . As hypothesized by Gassull et al. (6) , another mechanism, whereby enteral nutrition could promote remission in CD, could be related to its fat content (21, 22) . Moreover, besides the amount of fat, diff erences in the are many others polymorphisms located in the same gene, and not examined in this study, which could modulate gene transcription and infl uence disease activity. Th is hypothesis is supported by the observations of Terry et al. (15) , who analyzed the eff ect of IL6 promoter haplotype on IL6 transcription. Th ey concluded that polymorphisms do not exist in isolation, and that it may be the combination of base changes at several sites that infl uences gene transcription and protein function.
With respect to the TNF polymorphism, it is interesting to observe that similar to Peeters et al. (16) , and although the polymorphism studied was diff erent, we also observed that despite not increasing the susceptibility to develop the disease, the TNF − 857C / T polymorphism was associated with an increase in disease activity. The cut-off point for total fat=76.7 g; saturated fat=24.7 g; monounsaturated fat=33.3 g, polyunsaturated fat=11.5 g; trans fat=0.7 g; n-3 PUFA=1.2 g; n-6 PUFA=7.6 g; and n-6 / n-3=7.3.
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type of dietary fat may also be important in modulating intestinal infl ammation (6) .
Most studies focusing on dietary fat have examined the antiinfl ammatory eff ect of n-3 fatty acids. Th ese essential fatty acids seem to have potent immunomodulatory eff ects, which are mediated mainly through the modulation of eicosanoid synthesis and also by altering cell membrane fl uidity, cell signal transduction, intra-luminal bacterial content, as well as gene expression (23) . Perhaps the most compelling evidence that n-3 PUFA may have a protective role in infl ammatory bowel disease as opposed to n-6 PUFA, which predominates in Western diet, comes from the epidemiological study published by Shoda et al. (24) , in which the authors reported an association between increased incidence of CD and increased intake of dietary fat, especially n-6 PUFA during the last decades. In this same year, Belluzzi et al. (25) , on a clinical trial, showed that supplementation with an enteric-coated fi sh oil preparation was more eff ective than placebo in maintaining remission in patients with CD who had a high risk of relapse. However, following this study, a number of experimental and clinical studies have examined the anti-infl ammatory eff ect of n-3 fatty acids in infl ammatory bowel disease, mainly in CD, yielding confl icting results. In With respect to monounsaturated fat, it is interesting to note that our results strongly support the study carried out by Gassull et al. (6) In this randomized controlled study, the authors have examined the eff ects of a n-6-vs. a n-9-enriched diet compared with conventional therapy with steroids, in the treatment of active CD. Th e trial was stopped prematurely because, as opposed to what was expected, patients treated with a n-9-enriched diet had a much lower response rate compared with the other two groups. To our knowledge, this is the fi rst human study further supporting the observations of Gassull et al. (6) that a diet rich in monounsaturated fat may be detrimental to CD patients, in the sense that it seems associated with a more active phenotype.
recently published meta-analyses (26) , the authors concluded that the available data were insuffi cient to draw any defi nitive conclusions.
In general, our results are in agreement with previous studies as a higher intake of total, saturated and monounsaturated fats were associated with a more active disease. Th e relationship between fat, specially saturated fat, and infl ammation is not new one. Th us, a diet rich in saturated fats, particularly trans fats, has been reported to increase monocyte production of TNF , IL1B, and IL6, and all pro-infl ammatory cytokines (27) . Conversely, high intakes of PUFAs, particularly n-3, were shown to decrease circulating levels of pro-infl ammatory cytokines (28) . Active disease was defi ned as Harvey -Bradshaw Index ≥ 4. Analyzed by multiple logistic regression. OR, adjusted for age and gender was determined using the values above or under nutrient median intake. The cut-off point for total fat = 76.7 g; saturated fat = 24.7 g; monounsaturated fat = 33.3 g, polyunsaturated fat = 11.5 g; trans fat = 0.7 g; n-3 PUFA = 1.2 g; n-6 PUFA = 7.6 g; n-6 / n-3 = 7.3. Combined genotype G174G IL6 and CC 857 TNF-and low intake was the reference category. All test interactions showed P > 0.05.
Guerreiro et al.
Another reason for the discrepancies observed with regard to the benefi cial or detrimental eff ect of several types of fat in CD activity, could also be ascribed to polymorphisms of cytokine genes. Th us, and in agreement with this study, Van Heel et al. (29) showed that the carriage of at least one copy of the allele TNF 857C / T was associated with a tendency to produce more TNF in the infl amed mucosa at the colonic level, leading to a higher infl ammatory situation. Further supporting this concept, Grimble et al. (4) have shown that in a group of healthy individuals, diff erent genotypes for TNF were not only associated with diff erent levels of TNF production, but also with diff erent sensitivities to the anti-infl ammatory eff ects of fi sh oil. Th e ability of fi sh oil to suppress the production of TNF was highest when the basal production of this cytokine was also higher. In this study, we also observed that there was a synergism between SNPs studied and types of fat ingested. Th e detrimental eff ect of a high intake of saturated or monounsaturated fat was even higher for carriers of the polymorphic alleles of 857C / T TNF or for the 174G / C IL6 genes. Furthermore, the polymorphic allele of TNF also acted as a promotor factor in the presence of a diet poor in n-3 fatty acids.
One major limitation of this study refers to the recall bias of FFQ, as quantifi cation of food intake during the past year might not be very accurate. However, in a recent study (30) aimed at evaluating which could be the more appropriate tool for measuring usual dietary intake when analyzing gene -diet interactions, the authors, while recognizing that multiple 24-h dietary recalls provide excellent detail on dietary practices, also recognize that multiple days are required making the costs prohibitive. Th ey further concluded that when a validated FFQ is available, as is our case, FFQ remains the most cost-eff ective tool of choice.
Another weakness of our study relates to the small number of patients included. However, all of our patients have a wellcharacterized phenotype and an extensive evaluation from the nutritional point of view (31) and, to our knowledge, this is the fi rst study examining the interactions between polymorphisms of pro-infl ammatory cytokine genes and the type of fat intake in modulating disease activity in patients with CD. An understanding of this interaction may explain inconsistencies in the literature and may allow more specifi c targeting for dietary recommendations in patients with CD.
